Compared to control mice, liver-specific overexpression of LONP1 alleviated hepatic steatosis and attenuated fibrosis progression in MASH mice. Liver samples from three control mice injected with AAV-3×flag and fed a CDAHFD for 8 weeks were used as the control group, while those from three mice injected with AAV-TBG-Lonp1 and similarly fed served as the treatment group (with successful viral overexpression). Proteomic sequencing was performed on liver samples from both groups to further investigate the mechanism by which LONP1 overexpression improves MASH.